As part of the U.S. government's ongoing public health response to the 2019 novel coronavirus (2019-nCoV), the U.S. Department of Health and Human Services (HHS) today announced the opening of an Easy Broad Agency Announcement (EZ-BAA) for development of 2019-nCoV diagnostics and is now accepting abstract submissions for potential funding.  Under this EZ BAA, the Biomedical Advanced Research and Development Authority (BARDA), part of the HHS Office of the Assistant Secretary for Preparedness and Response (ASPR), will review concise abstract submissions for development funding of 2019-nCoV molecular diagnostics. The diagnostics must utilize platforms already cleared by the U.S. Food and Drug Administration, with a viable plan to meet requirements for the FDA to consider Emergency Use Authorization (EUA) within 12 weeks of an award.

"Diagnostics in close proximity to the patient are essential to ensure appropriate, prompt care and to help curb the spread of infectious diseases such as 2019-nCoV," said BARDA Director Rick Bright, PhD. "The 2019-nCoV poses a serious global health challenge, and at BARDA we are working rapidly with our government and industry partners to accelerate development of medical products needed to help protect the health of the American people."

To read the full press release, please follow this link: https://www.hhs.gov/about/news/2020/02/05/hhs-seeks-abstract-submissions-for-2019-ncov-diagnostics-development.html.  

As part of a multi-pronged response to the 2019-NcoV outbreak, BARDA has set up a website (see link below) to perform market research and keep the government informed about technologies that can be used to develop effective countermeasures against the coronavirus.  Please note that this is only market research and there is no guarantee of any funding based on the information the company may provide—but it is important to hear from
your relevant stakeholders.

https://www.medicalcountermeasures.gov/app/barda/coronavirus.aspx

To support ongoing U.S. Government 2019-nCoV medical countermeasure development efforts, BARDA is pleased to open our EZ BAA program and seeks abstract submissions for select 2019-nCoV diagnostics only. Please see solicitation BAA-20-100-SOL-0002  AOI #4: 2019-nCoV for more information, and apply here.

Please see the following link on the DRIVe site: https://drive.hhs.gov/partner.html

Please Note: Special Instruction Added to EZ BAA-20-100-SOL-0002 - Coronoavirus - AOI #4.2

Another special instruction for COVID-19 was added to the EZ BAA, called AOI 4.2 (Non-clinical Models). 

Here is the website to the EZ-BAA: https://beta.sam.gov/opp/560c7b048beb446b9ddf5e12744daf95/view

AOI #4 will be open for abstract submissions until 1700 HRS ET on 18 March 2020, unless otherwise extended. Additionally, award(s) expected to be made under these Special Instructions 002 will be less than $750,000 in total government funding.

 Abstract submissions that do not conform to the requirements outlined in the EZ-BAA may be considered non‐responsive and will not be reviewed.

NOTE: Funding is limited, so we encourage any interested vendors to reach out to the appropriate Program Manager listed above before submitting an abstract as soon as possible.

ASPR NEXT PROPOSAL ON FEDBIZOPPS.GOV

The Assistant Secretary for Preparedness and Response (ASPR)  is soliciting proposals for revolutionary advancements in health security products, technologies and innovations, specifically to invigorate operations, response, recovery and medical countermeasure development, deployment and distribution activities. ASPR is seeking innovative proposals to investigate approaches that enable revolutionary advances in science, technologies, or systems. Specifically excluded are basic science, research, development, prototype and process development, data science, clinical studies, and other activities that primarily result in evolutionary improvements to the existing state of the art. ASPR is seeking approaches that are outside the mainstream, challenge assumptions, and have the potential to radically change established practice, lead to extraordinary outcomes, and create entirely new fields and commercial market disruptions with wide-ranging impact that will protect Americans from 21st Century Health Threats.

ASPR Next Areas of Interest

AOI-1: Priority Medicines on Demand

Development of transformational devices for end-to-end pharmaceutical, vaccine and/or biologics production in small-scale, modular, continuous manufacturing platforms. ASPR is also interested in developing technologies that can transform drinking water to water for sterile injection, complete with physiological additives suitable for infusion, for production at point-of-delivery.

AOI-2: Dialysis Care in Disaster Settings

Development of next-generation, portable technologies for hemodialysis in disaster settings.

AOI-3: Medical Countermeasure Deployment and Dispensing

Development of capabilities to ensure rapid deployment and dispensing of medical countermeasures or other materials to emergency response locations. This is inclusive of, but not limited to, alternate delivery methods and dispensing solutions and the development of alternative delivery platforms for pharmaceutical, vaccine and biologic administration.

AOI-4: Real-Time Healthcare System Capacity Reporting

Develop capabilities that enable secure, confidential and controlled means to track healthcare provider capacity to respond to disasters in a dynamic and timely fashion.

AOI-5: Disaster Response and Recovery Intelligence

Develop capabilities that bring together deep learning, Artificial Intelligence and Machine Learning applications to forecast disaster impacts and automate replenishment of supplies during disasters.

AOI-6: Advanced Medical Interventions

Develop capabilities to address advanced health security vulnerabilities, establish trusted data platforms to secure health-related information and investigate linkages between clinical manifestation of disease and multi-omic indicators within dedicated US-based facilities to open new pipelines for medical countermeasure discovery

AOI-7: Telehealth Applications for Response and Recovery

Establish telehealth services for medical professionals and para-professionals to better assist state, local, tribal and territorial health systems during disaster response and recovery. These teams of medical professionals and para-professionals include advanced clinicians (nurse practitioners/physician assistants), medical officers, registered nurses, respiratory therapists, paramedics, pharmacists, safety specialists, logistical specialists, information technologists, communication and administrative specialists.

AOI-8: Health Security Innovation

This Area of Interest seeks revolutionary research ideas for topics not being addressed by ongoing ASPR programs or other published solicitations.

Contracting Office Address:

Office of the Assistant Secretary for Preparedness & Response (ASPR)
Department of Health and Human Services
330 Independence Ave. SW
G640
Washington, District of Columbia 20201
United States

Primary Point of Contact.:

Tasha McMillian,
Contracting Officer
Tasha.McMillian@hhs.gov
Phone: 202-205-1502
Fax: 202-260-0264

The United States Army Medical and Materiel Command's (USAMRMC) mission is to provide solutions to medical problems of importance to the American Service member at home and abroad, as well as to the general public at large. Extramural research and development programs play a vital role in the fulfillment of the objectives established by the USAMRMC.

The FY18-FY22 USAMRMC Broad Agency Announcement (BAA) is intended to solicit extramural research and development ideas. Research and development funded through the BAA are intended and expected to benefit and inform both military and civilian medical practice and knowledge.
Read more information.